Overview

Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
An explorative study of the Mantis Photonics hyperspectral camera for retinal imaging and estimation of retinal oxygenation. Primary objective: To evaluate the performance of the hyperspectral camera for non-invasive retinal examination in order to improve the diagnosis of diseases affecting the retina or central nervous system. Secondary objective: To investigate the possibilities of the use of a hyperspectral camera for non-invasive retinal examination.
Phase:
N/A
Details
Lead Sponsor:
Mantis Photonics AB
Collaborator:
Sundets Ögonläkare
Treatments:
Tropicamide